Deleterious mutations of the ryanodine receptor family, and especially the RYR2 receptor, lead to a constellation of pathologies leading to both acute and chronic heart failure collectively known as "Ryanopathies."[REF] .
Mice with genetically reduced RYR2 exhibit a lower basal heart rate and fatal arrythmias [REF].